MMP9 and B-cell chronic lymphocytic leukemia: We recently showed that matrix metalloproteinase-9, a common component of the CLL microenvironment, contributes to the CLL resistance to ATO and fludarabine by preventing downregulation of anti-apoptotic proteins of the Bcl-2 family [16].